USA flag logo/image

An Official Website of the United States Government

PERMANENT ANTIMICROBIAL MEDICAL PLASTIC

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
89382
Program Year/Program:
2008 / SBIR
Agency Tracking Number:
NR011117
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
GENOMEX
231-J E. Johnson St CARY, NC 27513-
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 2008
Title: PERMANENT ANTIMICROBIAL MEDICAL PLASTIC
Agency: HHS
Contract: 1R43NR011117-01
Award Amount: $99,999.00
 

Abstract:

DESCRIPTION (provided by applicant): Technology innovations to reduce infection brought about by cross- contamination of patients staying in healthcare facilities can have major significance to the medical community in terms of both dollars and human lives . Approximately 5% to 10% of all patients entering a hospital will contact some form of infection during their stay at the healthcare facility. It is estimated that hospitals spend over 5 billion annually and over 100,000 lives can be lost as a result of nosocomial infections. Statistics show that personal hygiene consisting mainly of hand washing with antimicrobial soaps does not occur frequently enough to prevent the 5 billion dollar expenditure that healthcare facilities endure on an annual basis. Unfo rtunately, medical products containing only 0.1-1.0% of leachable antimicrobial additives only provide temporary antimicrobial action because the biocidal agent can be easily removed by washing or wiping the surface of the medical product. Brighton Develop ment has developed a 100% permanent antimicrobial plastic that can be used in numerous medical products found in the healthcare community. In Phase I, we would like to focus on exploiting the feasibility of this discovery as a permanent antimicrobial mater ial and demonstrate its advantages in combating infection in the healthcare environment. PUBLIC HEALTH RELEVANCE: This application is aimed at developing a permanent antimicrobial medical plastic that can be used to reduce the billions of dollars spent ann ually by healthcare facilities to combat patient infections. Statistics show that the magnitude of this problem affects from 5-10% of all people entering the hospital and accounts for annual expenditures by the medical community of over 5 billion dollars e ven with documented frequencies of antimicrobial hand washing by hospital staff. A truly durable antimicrobial plastic material could find numerous uses in medical products throughout healthcare facilities.

Principal Investigator:

Joel L. Williams
9194671473
POLLYMAN4U@AOL.COM

Business Contact:


pollyman4u@aol.com
Small Business Information at Submission:

GENOMEX
231-J E. Johnson St CARY, NC 27513

EIN/Tax ID: 562128971
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No